Oncology-based In-Vivo CRO Industry

Global Oncology-based In-Vivo CRO Industry is expected to attain US$ 2.9 Billion by 2033, growing consistently at a 10.9% CAGR, according to FMI

The global oncology-based in-vivo CRO industry size is worth US$ 1.1 Billion as of now and is expected to reach US$ 2.9 Billion by the year 2033 at a notable CAGR of 10.9% between 2023 and 2033. The WHO states that as of the year 2020, 19.3 Million novel cases of cancer were reported along …

Continue reading “Global Oncology-based In-Vivo CRO Industry is expected to attain US$ 2.9 Billion by 2033, growing consistently at a 10.9% CAGR, according to FMI”